Edeny Bernstein News Today

Prescribing medication for alcohol use disorder on hospital discharge was associated with a significant decrease in the risk for an alcohol-related rehospitalization.

For patients with alcohol-related hospitalization, discharge initiation of US FDA-approved MAUD is linked to a reduction in the incidence of all-cause mortality or return to hospital within 30 days.

A new study showed how taking alcohol use disorder medication following an alcohol-related hospitalization discharge was linked to a reduction in return to hospital in 30 days.

Discharge initiation of US Food and Drug Administration-approved MAUD is associated with a reduction in the incidence of all-cause mortality.

MONDAY, April 1, 2024 (HealthDay News) -- For patients with alcohol-related hospitalization, discharge initiation of U.S. Food and Drug Administration-approved medications for alcohol use disorder (MAUD) is associated with a reduction in the incidence of all-cause mortality or return to hospital within 30 days, according to a study published online March 29 in JAMA Network

Patients hospitalized for alcohol use disorder (AUD) rarely initiate medications for AUD after discharge, according to study findings.

Patients hospitalized for alcohol use disorder (AUD) rarely initiate medications for AUD (MAUD) after discharge.

Strongest demographic predictor for discharge initiation of medications for alcohol use disorder was younger age.

Healthcare providers are missing opportunities to give medical treatment to high-risk individuals hospitalized for alcohol use disorder.